Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in early-stage unfavorable Hodgkin Lymphoma: final analysis of the randomized German Hodgkin Study Group Phase II NIVAHL trial - Bröckelmann, Paul Jan; Bühnen, Ina; Meißner, Julia; Trautmann-Grill, Karolin; Herhaus, Peter; Halbsguth, Teresa V.; Schaub, Valdete; Kerkhoff, Andrea; Mathas, Stephan; Bormann, Matthias; Dickhut, Andreas; Kaul, Helen; et al. (Journal of clinical oncology, 2023)
Online veröffentlicht: 12. Dezember 2022